https://www.biospace.com/calithera-biosciences-reports-cantata-study-of-telaglenastat-in-renal-cell-carcinoma-did-not-achieve-primary-endpoint
Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small-molecule drugs for the...
biosciencesreportscantatastudyrenal
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.567970/full
ATP6V1s participate in the biological process of transporting hydrogen ions and are associated with various cancers in expression and clinicopathological fea...
family membersfrontierscomprehensiveanalysisrenal
https://www.goodrx.com/conditions/renal-cancer/treatments-for-advanced-kidney-cancer
There are many treatment options for advanced kidney cancer (renal cell carcinoma). Some of the most common are targeted therapies and immunotherapy.
renal cell carcinomakidney cancertreatmentsoptionsadvanced
https://pubmed.ncbi.nlm.nih.gov/29988298/
Metastatic lesions of the nasal cavity and paranasal sinuses are rare tumors. Carcinomas originating from intrapelvic organs play an important role in the...
renal cell carcinomanasal septummetastaticcase
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1343027/full
PAGE \* Arabic \* MERGEFORMAT 3A corrigendum refers to a change to their article that the author wishes to publish after publication. The publication of this...
frontierscorrigendumphaseclearstudy
https://www.cancer.gov/ccg/research/structural-genomics/tcga/studied-cancers/papillary-renal-cell-carcinoma
A summary of TCGA's study of papillary renal cell (kidney) carcinoma, including what was known prior to the study and main findings from the characterization...
renal cell carcinomapapillarystudynci